Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- Check5 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed; no other core content or critical data changes.SummaryDifference0.4%
- Check12 days agoChange DetectedThe page has been updated to include new study status contacts and locations for dates in September 2025, while the previous version from August 2025 has been removed.SummaryDifference2%
- Check19 days agoChange DetectedThe web page has added a facility name and location details, along with a series of study status updates extending into 2025, while removing some location-related terms and specific dates.SummaryDifference100%
- Check27 days agoChange DetectedThe date for an event has been updated from August 14, 2025, to August 20, 2025.SummaryDifference0.3%
- Check34 days agoChange DetectedThe web page has been updated to a new version, v2.16.12, and the previous version, v2.16.11, has been removed. Additionally, a date of 2025-08-14 has been added.SummaryDifference0.6%
- Check41 days agoChange DetectedThe web page has updated its version from v2.16.10 to v2.16.11 and changed the date from 2025-07-30 to 2025-08-06.SummaryDifference1.0%
Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.